| (V316) |
The BMP-antagonist Grem1 binds “macrophage migration inhibitory factor” (MIF) with high affinity in vitro and blocks MIF-induced TNFα-secretion of human macrophages |
|
I. I. Müller, M. Lang, M. Schneider, F. Appenzeller, M. Stang, H. Schönleber, J. Pohl, S. Etzel, P. Seizer, T. Simmet, M. Gawaz (Tübingen, Ulm) |
| (V317) |
KC fails to induce neutrophil infiltration and neoangiogenesis in mouse model of myocardial infarction |
|
H. Oral, O. Postea, I. Kanzler, N. Tuchscheerer, A. Schuh, C. Weber, E. Liehn (Aachen, München) |
| (V318) |
Interleukin 23-signaling protects from myocardial inflammation, decreases ventricular rupture and reduces mortality in an experimental model of subacute myocardial infarction |
|
K. Savvatis, D. Westermann, A. Riad, M. Becher, K. Pappritz, C. Zietsch, H.-P. Schultheiss, C. Tschöpe (Berlin, Greifswald) |
| (V319) |
T-Zell-Rezeptor Vbeta Dominanz bei Myokarditis und inflammatorischer Kardiomyopathie |
|
M. Noutsias, V. Patil, B. Maisch (Marburg) |
| (V320) |
Autoantibodies in Dilated Cardiomyopathy control VEGF expression in Ventricular Myocytes |
|
E. Saygili, A. F. Noor-Ebad, E. Saygili, J. Weis, P. Schauerte, N. Marx, M. Kelm, C. Meyer, O. R. Rana (Düsseldorf, Aachen) |
| (V321) |
The Toll-like receptor 4 ligands S100A8 and S100A9 are crucial factors in viral cardiomyopathy |
|
C. Tschöpe, M. Becher, T. Vogl, D. Westermann, D. Lindner, K. Savvatis, J. Roth, H.-P. Schultheiss (Berlin, Münster) |